News
A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...
Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best CRISPR stocks to buy. On June 24, Thermo Fisher Scientific Inc.
Researchers at the University of California Davis Comprehensive Cancer Center have uncovered an evolutionary change that may ...
14h
News Medical on MSNStudy unveils powerful strategy to rejuvenate effectiveness of CAR T cell therapy against glioblastomaA team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...
A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...
A Martin County family with a child fighting rare cancer is getting help from the community to get treatment abroad.
1d
News-Medical.Net on MSNLeukemia-on-a-chip offers breakthrough in personalized cancer treatmentA team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...
During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $69.0, a high ...
1d
Interesting Engineering on MSNCredit-card-sized chip reveals how immune cells hunt and kill cancer in real timeEngineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.
Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results